APOA1 antibody (N-Term)
Quick Overview for APOA1 antibody (N-Term) (ABIN1888023)
Target
See all APOA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 17 amino acid peptide from near the amino terminus of human ApoA1.
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
-
Handling Advice
- Avoid freezing and thawing repeatly.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C for short term use.Store at -20 °C for long term preservation.
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Alternative Name
- ApoA1
-
Background
-
Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma.ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion.It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters.Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.
Synonyms: ApoA1, Apolipoprotein A1, ApoAI -
UniProt
- P02647
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-